Events & Presentations
June 17, 2010
Subcutaneous (SC) administration of SBI-087 provides potent B-cell depletion in subjects with controlled RA
Oral Presentation
June 17, 2010; 10:30 a.m.-Noon
B-cell depletion in subjects with controlled systemic lupus erythematosus (SLE) after intravenous or subcutaneous administration of SBI-087
Poster Presentation
June 19, 2010; 10:15-Noon
EULAR 2010 SBI-087 RA Phase 1 Presentation
277.8 KB
2010 EULAR SBI-087 SLE Phase 1 Presentation
1.7 MB
Return to Events & Presentations.
